Top segments and regional performance

Last year, the company generated 398.99 M USD, the most of which — 398.99 M USD — came from its top-performing segment, Innovative Therapies, compared to 266.72 M USD the previous year. The greatest contribution came from Greater China and United States, which accounted for 398.99 M USD last year, with 266.72 M USD the year before.